Antithrombotic Therapy for Venous Thromboembolic Disease.
نویسندگان
چکیده
I t has been recognized for more than a century that For venous thrombosis, stasis and local alterations in stasis of blood, abnormalities of the vessel wall, blood elements are most important, since major and changes in the soluble and formed elements of pathologic changes are not seen routinely in the vessel the blood are the major contributors to thrombosis. wall at the nidus of a venous thrombus. Reprint requests: Dr. Hyers, Znternul Medicine (hlmonology), St. Antithrombotic regimens are available that modlfy ~ o u i . Uniuersity, 3635 Vita Awnue, st. h i . % ~ i s s w r i 63110 one or more of these abnormalities. These modalities
منابع مشابه
Antithrombotic Therapy for Venous Thromboembolic Disease
I t has been recognized for over a century that stasis of blood, abnormalities of the vessel wall, and changes in the soluble and formed elements of the blood are the major contributors to thrombosis. For venous thrombosis, stasis and local alterations in blood elements are most important, since major pathologic changes are not routinely seen in the vessel wall at the nidus of a venous thrombus...
متن کاملDiagnosis of thromboembolic disease: Combined ventilation perfusion lung scan and compression ultrasonography
The clinical management of pulmonary embolism and deep venous thrombosis of the legs are similar and requires prolonged anticoagulation therapy. The standard diagnostic approach in patients suspected of pulmonary embolism is ventilation-perfusion (V/Q) lung scan and compression ultrasonography to detect deep venous thrombosis. This retrospective study analyzed the role of V/Q lung scan an...
متن کاملThrombolytic Therapy ACCP Conference on Antithrombotic and Thromboembolic Disease: The Seventh Antithrombotic Therapy for Venous
2004;126;401-428 Chest Martin H. Prins and Gary E. Raskob Harry R. Büller, Giancarlo Agnelli, Russel D. Hull, Thomas M. Hyers, Thrombolytic Therapy ACCP Conference on Antithrombotic and Thromboembolic Disease: The Seventh Antithrombotic Therapy for Venous http://chestjournal.org/cgi/content/abstract/126/3_suppl/401S and services can be found online on the World Wide Web at: The online version o...
متن کاملProphylactic antithrombotic therapy for patients with systemic lupus erythematosus with or without antiphospholipid antibodies: do the benefits outweigh the risks? A decision analysis.
BACKGROUND A high incidence of both arterial and venous thromboembolic events has been reported in patients with systemic lupus erythematosus (SLE), but the risks and benefits of primary prophylactic antithrombotic therapy have not been assessed. We measured the clinical benefit of 3 antithrombotic regimens in patients with SLE without antiphospholipid antibodies, with anticardiolipin antibodie...
متن کاملDabigatran etexilate - A novel oral anticoagulant for bleeding complications
Thromboembolic disease is a common cause of morbidity and mortality. Thrombin plays a key role in thrombotic events and thrombin inhibition represents a therapeutic event for thromboembolic events and has been identified as a target of therapy of its pivotal role in coagulation process. Anticoagulation is a major intervention for the management of arterial and venous thromboembolic events. Dabi...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Chest
دوره 108 4 Suppl شماره
صفحات -
تاریخ انتشار 1986